Allstate Corporation’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-17,333
Closed -$1.78M 792
2021
Q4
$1.78M Sell
17,333
-5,033
-23% -$483K 0.03% 427
2021
Q3
$1.96M Buy
22,366
+17
+0.1% +$1.54K 0.08% 135
2021
Q2
$2M Sell
22,349
-4,628
-17% -$391K 0.07% 140
2021
Q1
$2.05M Buy
26,977
+1,016
+4% +$76.6K 0.06% 151
2020
Q4
$1.77M Buy
25,961
+1,406
+6% +$87.7K 0.05% 159
2020
Q3
$1.31M Buy
24,555
+2,810
+13% +$167K 0.04% 180
2020
Q2
$1.27M Hold
21,745
0.04% 197
2020
Q1
$857K Sell
21,745
-4,556
-17% -$266K 0.03% 237
2019
Q4
$1.56M Buy
+26,301
New +$1.41M 0.03% 354

Other funds holding SYNH

Allstate Corporation's SYNH Position: Q1 2022 in Review

Allstate Corporation sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 17,333 shares — an estimated $1.78M sold.

Allstate Corporation first reported a position in SYNH in Q4 2019 and held it in 9 quarters. The position peaked at $2.05M in Q1 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • Allstate Corporation reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 17,333 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.78M.
  • Allstate Corporation first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 9 quarters.
  • Allstate Corporation's Syneos Health, Inc. Class A Common Stock position peaked at $2.05M in Q1 2021.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.